Management of acute ischemic stroke

Mayo Clinic Proceedings

Volumn 79, Issue 11, 2004, Pages 1459-1469

  Fulgham, Jimmy R ^a   Ingall, Timothy J ^b   Stead, Latha G ^a   Cloft, Harry J ^a   Wijdicks, Eelco F M ^a   Flemming, Kelly D ^a  

^a Mayo Clinic   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; HEPARIN; PROUROKINASE; UROKINASE;

AORTA DISSECTION; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE MONITORING; BRAIN BLOOD FLOW; BRAIN HEMORRHAGE; BRAIN INFECTION; BRAIN INJURY; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONTUSION; DECUBITUS; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DRUG INTOXICATION; DRUG MEGADOSE; EMERGENCY HEALTH SERVICE; EMERGENCY WARD; EPILEPSY; FIBRINOLYTIC THERAPY; HOSPITAL PATIENT; HOSPITAL PERSONNEL; HUMAN; HYPOGLYCEMIA; INTENSIVE CARE; MIGRAINE; NURSE ATTITUDE; OUTPATIENT CARE; PRACTICE GUIDELINE; PROGNOSIS; RECANALIZATION; RESPIRATORY CARE; TREATMENT OUTCOME;

EID: 7544243382     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/79.11.1459     Document Type: Conference Paper

References (44)

1. Kothari RU, Pancioli A, Liu T, Brott T, Broderick J. Cincinnati Prehospital Stroke Scale: reproducibility and validity. Ann Emerg Med. 1999;33:373-378.
2. Llanes JN, Kidwell CS, Starkman S, Leary MC, Eckstein M, Saver JL. The Los Angeles Motor Scale (LAMS): a new measure to characterize stroke severity in the field. Prehosp Emerg Care. 2004;8:46-50.
3. Tirschwell DL, Longstreth WT Jr, Becker KJ, et al. Shortening the NIH Stroke Scale for use in the prehospital setting. Stroke. 2002;33:2801-2806.
4. American Heart Association, International Liaison Committee on Resuscitation. Guidelines 2000 for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care, part 7: the era of reperfusion: section 2: acute stroke. Circulation. 2000;102(8, suppl):I204-I216.
5. Kothari R, Jauch E, Broderick J, et al. Acute stroke: delays to presentation and emergency department evaluation. Ann Emerg Med. 1999;33:3-8.
6. Spilker JA. Overview: the importance of patient and public education in acute ischemic stroke. In: Proceedings of a National Symposium on Rapid Identification and Treatment of Acute Stroke. Bethesda, Md: National Institute of Neurological Disorders and Stroke; 1997:119-126.
7. Bratina P, Greenberg L, Pasteur W, Grotta JC. Current emergency department management of stroke in Houston, Texas. Stroke. 1995;26:409-414.
8. Stead LG. Antiplatelet agents for acute ischemic stroke. Ann Emerg Med. 2003;42:423-425.
9. Adams HP Jr, Adams RJ, Brott T, et al, Stroke Council of the American Stroke Association. Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. Stroke. 2003;34:1056-1083.
10. Saxena R, Koudstaal PJ. Anticoagulants for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischaemic attack [Cochrane Review]. Cochrane Library. 2003;3. Available at: www.update-software.com/abstracts/AB000185.htm. Accessibility verified September 20, 2004.
11. Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset: the ATLANTIS Study: a randomized controlled trial. JAMA. 1999;282:2019-2026.
12. Donnan GA, Davis SM, Chambers BR, et al, Australian Streptokinase (ASK) Trial Study Group. Streptokinase for acute ischemic stroke with relationship to time of administration. JAMA. 1996;276:961-966.
13. Multicentre Acute Stroke Trial-Italy (MAST-1) Group. Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Lancet. 1995;346:1509-1514.
14. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274:1017-1025.
15. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
16. Marler JR, Tilley BC, Lu M, et al. Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study. Neurology. 2000;55:1649-1655.
17. Lewandowski CA, Frankel M, Tomsick TA, et al. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke. 1999;30:2598-2605.
18. Wijdicks EFM, Nichols DA, Thielen KR, et al. Intra-arterial thrombolysis in acute basilar artery thromboembolism: the initial Mayo Clinic experience. Mayo Clin Proc. 1997;72:1005-1013.
19. Jungreis CA, Wechsler LR, Horton JA. Intracranial thrombolysis via a catheter embedded in the clot. Stroke. 1989;20:1578-1580.
20. Barr JD, Mathis JM, Wildenhain SL, Wechsler L, Jungreis CA, Horton JA. Acute stroke intervention with iritraarterial urokinase infusion. J Vasc Interv Radiol. 1994;5:705-713.
21. del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke. 1998;29:4-11.
22. Furlan A, Higashida R, Wechsler L, et al, PROACT Investigators. Intraarterial prourokinase for acute ischemic stroke: the PROACT II study: a randomized controlled trial. JAMA. 1999;282:2003-2011.
23. Hahnel S, Schellinger PD, Gutschalk A, et al. Local intra-arterial fibrinolysis of thromboemboli occurring during neuroendovascular procedures with recombinant tissue plasminogen activator. Stroke. 2003;34:1723-1728.
24. Cloft HJ, Samuels OB, Tong FC, Dion JE. Use of abciximab for mediation of thromboembolic complications of endovascular therapy. AJNR Am J Neuroradiol. 2001;22:1764-1767.
25. Workman MJ, Cloft HJ, Tong FC, et al. Thrombus formation at the neck of cerebral aneurysms during treatment with Guglielmi detachable coils. AJNR Am J Neuroradiol. 2002;23:1568-1576.
26. Nakano S, Iseda T, Yoneyama T, Kawano H, Wakisaka S. Direct percutaneous transluminal angioplasty for acute middle cerebral artery trunk occlusion: an alternative option to intra-arterial thrombolysis. Stroke. 2002;33:2872-2876.
27. Ueda T, Sakaki S, Nochide I,Kumon Y,Kohno K, Ohta S. Angioplasty after intra-arterial thrombolysis for acute occlusion of intracranial arteries. Stroke. 1998;29:2568-2574.
28. Kerber CW, Barr JD, Berger RM, Chopko BW. Snare retrieval of intracranial thrombus in patients with acute stroke. J Vasc Interv Radiol. 2002;13:1269-1274.
29. Wikholm G. Transarterial embolectomy in acute stroke. AJNR Am J Neuroradiol. 2003;24:892-894.
30. Counsell C, Sandercock P. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke. Cochrane Database Syst Rev. 2001;4:CD000119.
31. Mayer SA, Copeland D, Bernardini GL, et al. Cost and outcome of mechanical ventilation for life-threatening stroke. Stroke. 2000;31:2346-2353.
32. Brown RD Jr. Management of hypertensive patients with cerebrovascular disease. In: Izzo JL Jr, Black HR, eds. Hypertension Primer: The Essentials of High Blood Pressure. 2nd ed. Baltimore, Md: Williams & Wilkins; 1999:396-397.
33. Weir CJ, Murray GD, Dyker AG, Lees KR. Is hyperglycaemia an independent predictor of poor outcome after acute stroke? results of a long-term follow up study. BMJ. 1997;314:1303-1306.
34. Wijdicks EFM, McMahon MM. Percutaneous endoscopic gastrostomy after acute stroke: complications and outcome. Cerebrovasc Dis. 1999;9:109-111.
35. Wijdicks EFM, Scott JP. Pulmonary embolism associated with acute stroke. Mayo Clin Proc. 1997;72:297-300.
36. Davenport RJ, Dennis MS, Warlow CP. Gastrointestinal hemorrhage after acute stroke. Stroke. 1996;27:421-424.
37. Wijdicks EFM, Fulgham JR, Batts KP. Gastrointestinal bleeding in stroke. Stroke. 1994;25:2146-2148.
38. Gladstone DJ, Black SE, Hakim AM, Heart and Stroke Foundation of Ontario Centre of Excellence in Stroke Recovery. Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions. Stroke. 2002;33:2123-2136.
39. Alternative Therapy Evaluation Committee for the Insurance Corporation of British Columbia. A review of the scientific evidence on the treatment of traumatic brain injuries and strokes with hyperbaric oxygen. Brain Inj. 2003;17:225-236.
40. Bernard SA, Gray TW, Buist MD, et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med. 2002;346:557-563.
41. Hypothermia After Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest [published correction appears in N Engl J Med. 2002;346:1756]. N Engl J Med. 2002;346:549-556.
42. Dalton Dietrich W, Kuluz JW. New research in the field of stroke: therapeutic hypothermia after cardiac arrest. Stroke. 2003;34:1051-1053.
43. Schaefer PW. Applications of DWI in clinical neurology. J Neurol Sci. 2001;186(suppl 1):S25-S35.
44. Wijdicks EFM. Management of massive hemispheric cerebral infarct: is there a ray of hope? Mayo Clin Proc. 2000;75:945-952.